Global Genetic (DNA) Testing Market Forecast, Trends, Share, Growth and Analysis Report By Inkwood Research

1
GENETIC TESTING MARKET FORECAST 2017-2024
www.InkwoodResearch.com
2
Report Description

• The global genetic testing market is Predicted to
  grow from 4614 million in 2016 to 9806 million
  by 2024, at a CAGR of 9.93 between 2016 and
  2024.
• The base year for the study is 2016 and the
  expected period is between 2017 and 2024.
• Genetic testing is one of the most rapidly
  growing segments in molecular diagnostics
  industry that helps in delivering customized
  health services and is also called as
  personalized medicine.

3
Objectives of the study

• According to the genetic testing market country
  outlook, currently, North America holds a
  dominant market share of in the global market.
• This growth of the North American genetic testing
  market is majorly due to the presence of major
  players in the market, higher disposable income,
  good health care infrastructure and increasing
  awareness about latest technologies.
• Asia Pacific genetic testing market is projected
  to report high growth rate during the forecast
  years. Good growth is expected due to favorable
  government policies which are spending more on
  Commercialization and RD of the technologically
  advanced products and the existence of larger
  target population due to more cases of chronic
  diseases.

4
Market Share
5
Report Insights

• The report provides detailed insights into the
  market, which is segmented by type, application,
  and region.
• The report includes all the major features of the
  gene testing market and provides an in-depth
  analysis over north america, europe, the
  asia-pacific region (apac), the middle east and
  africa (mea), and latin america.
• The major players for the genetic testing market
  are MOLECULARMD corp (US), DAAN Diagnostics Ltd.
  (Canada), GENENTECH, inc(US), inc.(US), ILLUMINA,
  Inc.(US), INTEGRAGEN S.A(France), GENOMICTREE,
  Inc.(South Korea), Myriad Genetics Inc.(US),
  Natera, Inc (US), Oxford Biodynamic Limited (UK),
  Pacific Biosciences Of California, Inc.(US), HTG
  molecular diagnostics, Perkinelmer Inc.(US),
  CEPHEID (US), QIAGEN N.V.(Netherland), LUMINEX
  corporation (US), Laboratory Corporation Of
  America Holdings (US), Roche Diagnostics
  Corporation(US). Illumina inc. (US) is the major
  players in the market.

6
Report Segmentation

• MARKET SEGMENTATION
• BY TYPE
• GLOBAL PREDISPOSITION TESTING MARKET
• GLOBAL DIAGNOSTIC TESTING MARKET 2017-2024
  (MILLION)
• GLOBAL NEWBORN SCREENING MARKET
• GLOBAL PRENATAL TESTING MARKET
• BY APPLICATION
• GLOBAL CANCER GENETIC TESTING MARKET
• GLOBAL PRENATAL GENETIC TESTING MARKET
• GLOBAL PHARMACOGENOMICS MARKET
• GLOBAL PREDISPOSITION MARKET
• KEY DATA ANALYTICS

• GEOGRAPHIC ANALYSIS
• NORTH AMERICA GLOBAL GENETIC TESTING MARKET
  2017-2024 ( MILLION)
• MARKET DETERMINANT ANALYSIS
• PREVALENCE OF CHRONIC DISORDERS ACROSS REGIONAL
  COUNTRIES
• REGIONAL ANALYSIS
• EUROPE GLOBAL GENETIC TESTING MARKET 2017-2024 (
  MILLION)
• MARKET DETERMINANT ANALYSIS
• REGIONAL ANALYSIS
• ASIA-PACIFIC GLOBAL GENETIC TESTING MARKET
• REGIONAL ANALYSIS
• REST OF THE WORLD GENETIC TESTING MARKET
• REGIONAL ANALYSIS

7
Request a Free Sample 

• To Request A Free Sample Copy Of This Report,
  Please Click The Link Below
• https//www.inkwoodresearch.com/reports/global-gen
  etic-testing-market-forecast-2017-2024

8
About Inkwood Research

• Inkwood Research specializes in syndicated
  research reports, customized research reports and
  consulting services. We offer market intelligence
  studies across a range of industries including
  Technology, Chemicals, Materials, Healthcare and
  Energy. With 20 years of research experience, we
  ensure you efficient deliverables with global and
  country industry knowledge and research
  expertise. Our analysis covers North South
  America, Europe, CEE, CIS, Middle East, Africa
  and Asia.

www.InkwoodResearch.com